InvestorsHub Logo

Ivest

03/02/10 3:10 PM

#400 RE: bart #399

Given the company has no cash, perhaps a hook-up or marketing agreement with potential partner(s)would be a good thing.

JJBenzo

03/02/10 6:33 PM

#403 RE: bart #399

Yes you are right with H1N1; it never became the big deal it was made out to be; but none the less its there if it pops up again.

No one can deny Arrayit has the single largest number of platforms installed worldwide; although revenue has been as high as 12 million in past years.(ACCORDING TO FIRST PUBLIC FILING) the platform race is not where huge revenues exist in future but I dare say it could.. The sleeping giant is the installed base is the biggest in the world and once scientist and pharma realize that huge biomarker discoveries are being made with Arrayit platforms combined with their H25K complete human genome chip. Arrayit revenues could explode through the sale of chips currently listed at $500 plus on their website.

You are certainly right about Parkinsons'; Prostate and others to follow. I am gambling on some major pharmas partnering soon.

The only thing holding back the company is capital, science is not the problem . The life science companies are infuego and I expect to hear of investment capital in Arrayit soon.(Just speculation) Eventually money hungry bankers will get to funding Arrayit.